tirzepatide patient handout does need to be kept cold not Advice on insulin storage: Always check the manufacturer's information leaflet for Tirzepatide Cold Chain Delivery Thailand – Informed consent for tirzepatide (Mounjaro®)

In the seventh step, the drug was administered with its own injector and desensitization was completed (Table 1)

Select state Medicaid programs may cover Wegovy for weight management in qualifying patients

Zhao J, et al

Most headaches experienced while taking Mounjaro are described as: Mild to moderate in intensity Often developing shortly after starting treatment or when the dose increases Typically improving within 2-4 weeks as your body adjusts Responding well to standard headache treatments like paracetamol Its worth noting that most people taking Mounjaro dont experience headaches at all, and for those who do, theyre rarely severe enough to require stopping the medication